الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> HCV>>TMC647055 Choline salt

TMC647055 Choline salt

رقم الكتالوجGC37802

TMC647055 (ملح الكولين) هو مثبط قوي للبوليميراز غير النوكليوزيد NS5B لتكرار HCV

Products are for research use only. Not for human use. We do not sell to patients.

TMC647055 Choline salt التركيب الكيميائي

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
445٫00
متوفر
2mg
185٫00
متوفر
5mg
278٫00
متوفر
10mg
417٫00
متوفر
50mg
1205٫00
متوفر
100mg
1947٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

TMC647055 choline salt is a cell-permeating, selective HCV NS5B inhibitor, eliciting a mean IC50 of 34 nM, as assessed in the RdRp primer-dependent transcription assay.IC50 value: 34 nM [1]Target: HCV NS5Bin vitro: TMC647055 is a novel and potent nonnucleoside inhibitor of the HCV NS5B RNA-dependent RNA polymerase. TMC647055 shows high selectivity for HCV when evaluated with a broad panel of human DNA and RNA viruses. TMC647055 shows median EC50 changes in the replicon assay of 9-, 3-, and 371-fold for L392I, V494A, and P495L, respectively, The median EC50 of TMC647055 on NS5B sequences derived from clinical isolates of genotypes 1a, 1b, 3a, 4a, and 6a ranged between 27 nM and 113 nM.[1]

[1]. Devogelaere B, et al. TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage. Antimicrob Agents Chemother. 2012 Sep;56(9):4676-4684.

مراجعات

Review for TMC647055 Choline salt

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TMC647055 Choline salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.